Axsome Therapeutics (AXSM) stock gains as the FDA accepts the company's marketing application for its narcolepsy therapy ...
The FDA has accepted Apnimed’s NDA for AD109 (aroxybutynin/atomoxetine), a potential first-in-class oral therapy for adults with obstructive sleep apnea.
Credit: Miller Kern / Mashable No one is seriously questioning whether red light therapy works at this point. The ...
Need a new TENS unit or buying your first one? Read our recommendations and discover our pick for the best TENS unit for home ...
The greatest therapeutic effects of psychedelics appear to occur long after the drug is gone. New research suggests they ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.
The Odyssey Audience Reviews: Epic Filmmaking That You Need to See on the Biggest Screen Possible Link to The Odyssey Audience Reviews: Epic Filmmaking That You Need to See on the Biggest Screen ...